Disclosures for "Analyzing the Cerebrovascular Disease-related Mortality Among Young Population in the United States From 1999 to 2024: A Comprehensive CDC WONDER Database Analysis"
-
Dr. John has nothing to disclose.
-
Dr. Azhar has nothing to disclose.
-
Dr. Usman has nothing to disclose.
-
Dr. Ramanan has nothing to disclose.
-
Dr. Isaza Pierotti has nothing to disclose.
-
Dr. Alboudi has nothing to disclose.
-
The institution of Dr. Saleemi has received research support from NIH.
-
The institution of Dr. abramov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BridgeBio. The institution of Dr. abramov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bayer. The institution of Dr. abramov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca.